寵物成藥市場規模、佔有率和成長分析：按動物類型、產品類型、劑型、分銷管道和地區分類－2026-2033年產業預測

2024 年全球非處方（成藥市場價值為 98 億美元，預計到 2033 年將從 2025 年的 103.8 億美元成長到 164.2 億美元，預測期（2026-2033 年）的複合年成長率為 5.9%。

全球寵物成藥市場受到放鬆管制的顯著影響，這使得新配方的推出速度更快、成本更低。簡化的核准流程使製造商能夠將資源投入數位行銷和銷售管道多元化，從而提高消費者的認知度。這一趨勢在訂閱式關節健康套裝的成長中尤為明顯，其銷售額實現了顯著成長。此外，人們對寵物預防保健和健康解決方案的興趣日益濃厚，推動了消費者對跳蚤和蜱蟲治療、維生素、關節補充劑、益生菌、牙齒護理產品和免疫支持配方等非處方藥產品的需求成長。隨著寵物飼主越來越重視寵物的長期健康管理，這一趨勢正在推動市場強勁成長，並為利基創新者進入市場創造了機會。

全球寵物非處方成藥市場成長要素

隨著寵物飼主越來越重視無需諮詢獸醫即可購買非處方藥的便利性，並傾向於在家處理寵物的小毛病，全球非處方成藥市場正在蓬勃發展。這一趨勢促使生產商拓展其非處方產品線，開發出針對常見寵物疾病的各種治療方案。消費者對自我護理信心的增強推動了這些便捷解決方案的銷售，同時也契合了許多寵物飼主忙碌的生活方式。這種對便利性的重視有效地推動了全球寵物保健產品產業的持續擴張。

全球寵物非處方成藥市場的限制因素

全球寵物非處方成藥市場面臨許多阻礙，主要原因是監管機構實施了嚴格的監管規定，要求進行嚴格的測試和標籤標註，以確保消費者安全。雖然這些措施對於保護寵物至關重要，但它們延長了產品研發週期，並要求製造商投入大量資金才能符合監管要求。這種額外的負擔會阻礙產品及時進入市場，推高成本，最終阻礙新型非處方藥的上市。因此，寵物飼主的選擇有限，而謹慎的監管環境也可能阻礙創新療法快速進入全球市場。

全球非處方成藥市場趨勢

由於專注於寵物健康的數位化平台的興起，全球成藥市場正經歷重大變革。這些平台透過行動應用程式和遠端獸醫服務，為寵物飼主提供個人化的用藥建議，從而徹底改變了非處方藥的取得方式。便利的訂購選項和訂閱模式的推出，透過數據驅動的互動，提升了品牌知名度，並培養了長期的客戶忠誠度。消費者在追求便利的健康解決方案的同時，也期望他們的寵物也能享受到同樣的便利。這一趨勢要求製造商專注於開發跨設備和管道的無縫電商體驗和虛擬醫療支持，以確保全面高效的購買流程。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 宏觀經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球寵物非處方成藥市場規模：以動物類型分類

• 狗
• 貓
• 馬
• 鳥
• 其他

全球寵物非成藥市場規模：依產品類型

• 殺蟲劑
• 跳蚤滅殺
• 蟎蟲滅殺
• 預防犬心絲蟲的藥物
• 有助於關節健康的補充劑
• 保養
• 行為健康產品
• 其他

全球寵物非成藥市場規模：以劑型分類

• 咀嚼片
• 藥片
• 外用滴劑
• 噴
• 衣領
• 粉末
• 液體

全球寵物非成藥市場規模：依分銷管道分類

• 動物診所
• 寵物專賣店
• 線上零售商
• 超級市場
• 藥局

全球寵物非成藥市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Merck & Co. Inc.
• Virbac SA
• Vetoquinol SA
• Ceva Sante Animale SA
• Dechra Pharmaceuticals PLC
• PetIQ Inc.
• Central Garden & Pet Company
• Nutramax Laboratories Inc.
• Seresto
• Farnam Companies Inc.
• Hartz Mountain Corporation
• Bayer AG
• Advanllard Inc.
• Midmark Corporation
• TropiClean Pet Products
• Ark Naturals Company
• Ourpet Company

結論與建議

Global OTC Pet Medication Market size was valued at USD 9.8 Billion in 2024 and is poised to grow from USD 10.38 Billion in 2025 to USD 16.42 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026-2033).

The global OTC pet medication market is significantly influenced by regulatory liberalization, enabling quicker and more cost-effective introduction of new formulations. Streamlined approval processes allow manufacturers to shift resources towards digital marketing and diversify sales channels, enhancing consumer awareness. This trend is exemplified by the growth of subscription-based joint-health kits, which have experienced impressive sales increases. Additionally, there is a growing emphasis on preventive pet healthcare and wellness solutions, with rising consumer demand for OTC products such as flea and tick treatments, vitamins, joint supplements, probiotics, dental care items, and immune-support formulations. As pet owners increasingly prioritize long-term health management for their pets, this momentum fosters a robust growth trajectory and presents opportunities for niche innovators to enter the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global OTC Pet Medication market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global OTC Pet Medication Market Segments Analysis

Global otc pet medication market is segmented by animal type, product category, formulation format, distribution channel and region. Based on animal type, the market is segmented into Dogs, Cats, Horses, Birds and Others. Based on product category, the market is segmented into Parasiticides, Flea Control, Tick Control, Heartworm Preventatives, Joint Health Supplements, Dermatological Care, Behavioral Health Products and Others. Based on formulation format, the market is segmented into Chewables, Tablets, Topical Drops, Sprays, Collars, Powders and Liquids. Based on distribution channel, the market is segmented into Veterinary Clinics, Pet Specialty Stores, Online Retailers, Supermarkets and Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global OTC Pet Medication Market

The Global OTC Pet Medication market is experiencing growth as pet owners show a growing preference for addressing minor health concerns from the comfort of their homes, appreciating the convenience of obtaining medications without the need for veterinary appointments. This trend motivates manufacturers to diversify their over-the-counter product offerings, creating a wider array of treatments that cater to common pet ailments. Increased confidence in self-care among consumers has led to a rise in the purchase of these accessible solutions, which resonates with the fast-paced lifestyles of many pet owners. This emphasis on convenience effectively drives continuous expansion in the pet health product sector worldwide.

Restraints in the Global OTC Pet Medication Market

The Global OTC Pet Medication market faces significant restraints due to stringent regulations imposed by governing authorities, which mandate rigorous testing and labeling requirements to ensure consumer safety. While these measures are necessary for safeguarding pets, they lengthen product development cycles and necessitate substantial investment from manufacturers to achieve compliance. This additional burden can hinder timely market entry and elevate costs, ultimately stifling the introduction of new over-the-counter products. As a result, a limited range of options is available to pet owners, and the cautious regulatory landscape may impede the rapid integration of innovative treatments within the global marketplace.

Market Trends of the Global OTC Pet Medication Market

The Global OTC Pet Medication market is experiencing a significant transformation driven by the rise of digital platforms dedicated to pet wellness. These platforms are revolutionizing access to over-the-counter medications by providing pet owners with personalized recommendations through mobile apps and tele-vet services. The integration of convenient ordering options and subscription models enhances brand visibility and fosters long-term loyalty through data-driven engagement. As consumers seek instant health solutions for themselves, their expectations are shifting towards similar conveniences for their pets. This trend compels manufacturers to focus on developing seamless e-commerce experiences and virtual care support across various devices and channels, ensuring a comprehensive and efficient purchasing journey.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global OTC Pet Medication Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Birds
• Others

Global OTC Pet Medication Market Size by Product Category & CAGR (2026-2033)

• Market Overview
• Parasiticides
• Flea Control
• Tick Control
• Heartworm Preventatives
• Joint Health Supplements
• Dermatological Care
• Behavioral Health Products
• Others

Global OTC Pet Medication Market Size by Formulation Format & CAGR (2026-2033)

• Market Overview
• Chewables
• Tablets
• Topical Drops
• Sprays
• Collars
• Powders
• Liquids

Global OTC Pet Medication Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Pet Specialty Stores
• Online Retailers
• Supermarkets
• Pharmacies

Global OTC Pet Medication Market Size & CAGR (2026-2033)

• North America (Animal Type, Product Category, Formulation Format, Distribution Channel)
  • US
  • Canada
• Europe (Animal Type, Product Category, Formulation Format, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Product Category, Formulation Format, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Product Category, Formulation Format, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Product Category, Formulation Format, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetIQ Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Central Garden & Pet Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seresto
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Farnam Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hartz Mountain Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanllard Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Midmark Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TropiClean Pet Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ark Naturals Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourpet Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations